Life Insurance (Prudential Rules) Determination No. 6 of 2005 - Prudential Rules No. 49 - Contract classification for the purposes of regulatory reporting to APRA (16/12/2005) (Cth)
I, John Francis Laker, Chair of APRA, under subsection 252(1) of the
• MAKE the Prudential Rules No. 49 set out in the Schedule for the purposes of subsection 82(5), paragraph 117(2)(d) and subsections 117(3), 244(1) and 244(2) of the Act.
This Determination shall take effect upon registration on the Federal Register of Legislative Instruments.
16 December 2005
[Signed]
John Francis Laker
Chair
In this Determination
Prudential Rules No. 49 comprise the 5 pages commencing on the following page.
These prudential rules are made under subsection 252(1) of the Life Insurance Act 1995 (the Act) for the purposes of subsection 82(5), paragraph 117(2)(d) and subsections 117(3), 244(1) and 244(2) of the Act and apply to life companies registered under the Act (including friendly societies).
In these Prudential Rules:
(a) that are likely to be a significant portion of the total contractual benefits;
(b) whose amount or timing is contractually at the discretion of the issuer; and
(c) that are contractually based on:
(i) the performance of a specified pool of contracts or a specified type of contract;
(ii) realised and/or unrealised investment returns on a specified pool of assets held by the issuer; or
(iii) the profit or loss of the company, fund or other entity that issues the contract
(a) an Insurance Contract that is regulated under the Act, or similar contracts issued by entities operating outside Australia; or
(b) a financial instrument with a discretionary participation feature, which is regulated under the Act, or similar contracts issued by entities operating outside Australia.
1. For life companies other than friendly societies these rules:
(a) take effect on 31 December 2005; and
(b) apply to regulatory reporting, and to valuations of policy liabilities made for that purpose, in respect of periods ending on or after 31 December 2005.
2. For life companies that are friendly societies these rules:
(a) take effect on 31 May 2006; and
(b) apply to regulatory reporting, and to valuations of policy liabilities made for that purpose, in respect of periods ending on or after 31 May 2006.
3. Under IFRS, the accounting treatment for a contract issued by a life company is determined on the basis of the benefits that the contract offers to the policyholder. A life company that offers different products (e.g. risk products and unit-linked investment products) is required to account for these products under different accounting standards. This differentiation will extend to the valuation of the liabilities of the products for regulatory reporting purposes under the Act.
The key distinction is between:
(a) Life insurance contracts - which are treated in accordance with the requirements of AASB 1038;
(b) General insurance contracts - which are treated under AASB 1023 General Insurance Contracts or AASB 4 Insurance Contracts; and
(c) Life investment contracts - which are treated under AASB 139 Financial Instruments: Recognition and Measurement, to the extent that they give rise to financial assets or financial liabilities, and AASB 118 Revenue to the extent that they also involve the provision of management services.
5. For regulatory reporting purposes, all contracts are to be valued in accordance with the Valuation Standard. The Valuation Standard makes a distinction between the measurement of life insurance contracts and life investment contracts in the same way as AASB 1038. (General insurance contracts are not covered by the Valuation Standard as they are not regulated under the Act.)
6. For the purpose of applying the Valuation Standard, the definitions of life insurance contract, life investment contract, insurance contract and discretionary participation feature are to be the same as the definitions applying under AASB 1038.
7. The definition of discretionary participation feature under AASB 1038 is not necessarily the same as the definition of a participating benefit under section 15 of the Act.
8. However, Prudential Rules No. 22 sets out criteria for defining certain benefits as non-participating under the Act which may also be of assistance in assessing whether the extent of discretion available under a contract is significant for the purpose of establishing whether the contract contains a discretionary participation feature.
9. For regulatory reporting purposes, a non-participating benefit that is otherwise deemed for general purpose reporting to contain a discretionary participation feature is to be treated under the Valuation Standard as a non-participating benefit with allowance made within the policy liabilities for the value of future discretionary additions, including any additions in respect of the current reporting period.
10. For regulatory reporting purposes, a participating benefit is deemed to satisfy the definition of a life insurance contract, even if it is classified as a life investment contract for general purpose reporting. In such circumstances a life company may, under subsection 15(4) of the Act, request that APRA declare the benefit to be non-participating, to allow the regulatory reporting treatment and the general purpose reporting treatment to be aligned.
11. Some contracts contain elements of both insurance contracts and deposits (i.e. investment contracts, with or without a discretionary participation feature). Sections 2.3.2 and 2.3.3 of AASB1038 permit such contracts to be unbundled into separate insurance contracts and deposit components if (and only if) the deposit component can be measured separately. However, the life company is not required to unbundle, and may therefore treat the entire contract as a life insurance contract if it so wishes.
12. For regulatory reporting purposes, the following contracts must not be unbundled:
(a) reinsurance contracts; and
(b) participating contracts with insurance riders, where the profits on the riders are deemed to be in respect of participating business and so allocated between policyholders and shareholders.
13. If not in conflict with rule 12 then, for regulatory reporting purposes, a contract must be unbundled if it can be split for the purpose of recognising premium revenue and claims expense under section 5 of AASB 1038.
14. If not in conflict with rule 12 then, for regulatory reporting purposes, where a contract contains both investment linked and discretionary investment benefit options, they must be unbundled as separate deposit components, with the associated service components apportioned between them.
15. If not in conflict with rule 12
0
0
0